Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Pharmeuropa Bio & Scientific Notes|January 19, 2013
On the formation of bromhexine impurity E and its chromatographic behaviourB J Venhuis, M Weda, D de Kaste, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 21, 2014
Potential association between the recent increase in campylobacteriosis incidence in the Netherlands and proton-pump inhibitor use - an ecological studyM Bouwknegt, W van Pelt, M E Kubbinga, et al.
International Journal of Pharmaceutics|September 25, 2002
Metal versus plastic spacers: an in vitro and in vivo comparisonR Janssen, M Weda, M B Ekkelenkamp, et al.
International Journal of Pharmaceutics|November 16, 2004
An investigation into the predictive value of cascade impactor results for side effects of inhaled salbutamolM Weda, P Zanen, A H de Boer, et al.
Pharmeuropa Scientific Notes|August 19, 2007
Disintegration of sublingual tablets: proposal for a validated test method and acceptance criterionM Weda, D A van Riet-Nales, P van Aalst, et al.
International Journal of Pharmaceutics|April 25, 2003
Drug output of unvented jet nebulizers as a function of timeH Diederik, P P H Le Brun, H W Frijlink, et al.
International Journal of Pharmaceutics|November 16, 2002
Equivalence testing of salbutamol dry powder inhalers: in vitro impaction results versus in vivo efficacyM Weda, P Zanen, A H de Boer, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 9, 2000
Equivalence testing and equivalence limits of metered-dose inhalers and dry powder inhalers measured by in vitro impactionM Weda, E R Geuns, R C Vermeer, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 26, 2010
Consistency of FMEA used in the validation of analytical proceduresM T Oldenhof, J F van Leeuwen, M J Nauta, et al.
Pageof 1